GDF15 and Alzheimer disease: In conclusion, while in our research, GDF15 appears not to be a reliable circulating marker of AD, it is nevertheless expressed in brain areas, and the processing into the mature form is higher in AD samples, where there is also an impairment of OXPHOS subunits expression, possibly indicating an attempt of the cells to rescue from a mitochondrial stress, as illustrated in Figure 8.